DocSym
β
Searchsearch
Search
(D01.5) Carcinoma in situ: liver, gallbladder and bile ducts
More details coming soon
112 913 in individuals diagnosis carcinoma in situ: liver, gallbladder and bile ducts confirmed
3 597 deaths with diagnosis carcinoma in situ: liver, gallbladder and bile ducts
3% mortality rate associated with the disease carcinoma in situ: liver, gallbladder and bile ducts
Diagnosis carcinoma in situ: liver, gallbladder and bile ducts is diagnosed Men are 9.90% more likely than Women
62 047
Men receive the diagnosis carcinoma in situ: liver, gallbladder and bile ducts
860 (1.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
50 866
Women receive the diagnosis carcinoma in situ: liver, gallbladder and bile ducts
2 737 (5.4 %)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: liver, gallbladder and bile ducts - Men and Women aged 70-74
In Men diagnosis is most often set at age 20-94
Less common in men the disease occurs at Age 0-19, 95+Less common in women the disease occurs at Age 0-24, 95+
In Women diagnosis is most often set at age 0-1, 25-94
Disease Features carcinoma in situ: liver, gallbladder and bile ducts
Absence or low individual and public risk
Carcinoma in situ: liver, gallbladder and bile ducts - what does this mean
Carcinoma in situ of the liver, gallbladder and bile ducts is a type of cancer in which abnormal cells are found in the lining of these organs but have not yet spread to any surrounding tissue. it can be caused by a variety of factors, such as exposure to certain toxins, genetic predisposition, or certain lifestyle factors. treatment typically involves surgery to remove the affected tissue, and may also include radiation therapy and chemotherapy.
What happens during the disease - carcinoma in situ: liver, gallbladder and bile ducts
Carcinoma in situ of the liver, gallbladder and bile ducts is a form of cancer in which the malignant cells are confined to the epithelial layer of the organs and have not spread to other tissues. it is thought to be caused by environmental factors such as exposure to certain toxins, chronic inflammation, and/or genetic mutations that lead to abnormal cell growth and proliferation. the malignant cells can form a mass or tumor which can block the bile ducts and lead to further complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical exam
- Imaging tests (CT scan, MRI, ultrasound)
- Blood tests (liver function tests, alpha-fetoprotein tests)
- Biopsy
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Endoscopic ultrasound (EUS)
- Laparoscopy
Treatment and Medical Assistance
Main goal of the treatment: To prevent the progression of Carcinoma in situ in the liver, gallbladder and bile ducts.
- Surgery to remove the affected tissue
- Chemotherapy to reduce the tumor size
- Radiation therapy to destroy cancer cells
- Targeted drug therapy to block the growth of cancer cells
- Immunotherapy to boost the body's immune system
- Hormonal therapy to reduce the growth of cancer cells
- Photodynamic therapy to destroy cancer cells
- Gene therapy to alter the genes of cancer cells
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carcinoma in situ: liver, gallbladder and bile ducts - Prevention
The best way to prevent carcinoma in situ of the liver, gallbladder and bile ducts is to maintain a healthy lifestyle and diet, avoid smoking and excessive alcohol consumption, and regularly check for any signs of abnormal growths or changes in the liver, gallbladder and bile ducts. early detection and prompt treatment can greatly reduce the risk of developing this disease.